ADAPY (ADAPY) Stock Price & Analysis
ADAPY (ADAPY) rose 3.85% to USD 0.03 as of September 8, 2026 at 08:17 UTC, according to Nexqual real-time market data.
ADAPY last closed at USD 0.03; the session ranged USD 0.02–0.03 on volume of 42,398 shares. Market capitalization is —, with a 52-week range of USD 0–0.28 (PNK). Source: Nexqual, September 8, 2026 at 08:17 UTC.
Key Statistics (as of September 8, 2026 at 08:17 UTC)
| Price | USD 0.03 |
|---|---|
| Change | ▲ 3.85% (up) |
| Previous Close | USD 0.03 |
| Open | USD 0.03 |
| Day Range | USD 0.02 – 0.03 |
| 52-Week Range | USD 0 – 0.28 |
| Volume | 42,398 shares |
| Market Cap | — |
| Exchange | PNK |
Technical Analysis (ADAPY)
Nexqual's technical model rates ADAPY "STRONG SELL" based on 0 bullish and 6 bearish signals across 128 daily candles, as of September 8, 2026 at 08:17 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 49.12 (neutral) |
| vs SMA50 | Below (USD 0.03) |
| MACD | -0 (negative) |
From ADAPY's Latest SEC 10-K Filing (filed 2025-03-24)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| AFMDQ | Affimed N.V. | USD 0 | ▲ 0% |
| CLLS | Cellectis S.A. | USD 3.24 | ▼ 0.31% |
| ATRA | Atara Biotherapeutics, Inc. | USD 9.76 | ▲ 3.39% |
| MGNX | MacroGenics, Inc. | USD 4.4 | ▲ 1.85% |
| CTMX | CytomX Therapeutics, Inc. | USD 3.71 | ▼ 0.27% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 08:17 UTC. This page is informational and not investment advice.